Prescription adherence technology provider iPill Dispenser has been named HealthTech Startup of the Month following a recent pitch session which took place during April’s HealthTech RapidConf.
The event which runs every month for members of our HealthTech Networking Club brings together innovative HealthTech startups with investors, consultants and other key stakeholders in the industry. Once a month 4 of these startups pitch their product and receive feedback from investors.
The winner receives a valuable package including a Product Acceleration from bene studio to plan their digital product further based industry best practices and their business goals.
iPill Dispenser is a digital health hardware innovation designed to improve prescription adherence and reduce opioid diversion and abuse through a secure dispenser and mobile application. The dispenser and app ensure that the prescribed person has access to opioids at the prescribed dose, safely disposes of unused opioids, and monitors patient respiration.
The company has seen great traction, including recognition by the US FDA for its potential as a device to prevent and treat opioid use disorder. In 2020, the company was named a winner of the 2020 American College of Cardiology Digital Health Innovation Award in association with AngelMD.
iPill Dispenser was joined in the pitch session by 3 other HealthTech Startups:
Drift Biotechnologies, a company developing bioinformatics software for microbial, particularly infectious disease genetic sequencing.
USCHAG, which develops artificial intelligence, machine learning and quantum processing to compare and contrast massive amounts of clean and control health care data.
Medical Cooling, a company that has developed a portable therapeutic hypothermic solution.
All the companies involved made compelling pitches to the judges, receiving valuable feedback from the panel.
Watch all the pitches online here
iPill Dispenser as HealthTech Startup of the Month
Commenting on being recognized as the HealthTech Startup of the Month CEO and Founder Dr. John Hsu said, “We hope to make the iPill a market leader that will become the standard of practice. The child-resistant cap was developed by Dr. Henri Breault in 1967 and made a federal mandate in 1970. Child hold overdoses dropped 91 percent. Kids have gotten smarter. 1 in 4 opioid overdoses now involves children and teens. By secure opioid storage, active control dispensing, destruction of unused pills upon tampering or prescription end, the iPill can save lives, reduce medical expenses, and improve healthcare.”
“This project has so many moving parts and we have been reaching milestone after milestone. We have 3 grants, an FDA breakthrough designation, an FDA Class I 510K exemption, a manufacturer, a distributor, a few purchase orders from customers, and in a recent development a lead investor.” concludes Hsu.
HealthTech Networking Club
iPill Dispenser is part of the HealthTech Networking Club, an invite-only networking club that connects key players in the Healthtech industry and provides private networking opportunities.
Become a member and network with John and other HealthTech, Telehealth, or IoMT startup leaders, consultants, investors, and healthcare providers. If your organization is a part of the HealthTech ecosystem, apply for an invitation to the HealthTech Networking Club here.
